Neuronetics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 06/30/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $149.2 | $74.9 | — | $71.3 | $65.2 |
| Operating income | -$31.4 | -$34.6 | — | -$30.6 | -$35.1 |
| Net income | -$39.0 | -$43.7 | — | -$30.2 | -$37.2 |
| Balance Sheet | |||||
| Total debt | $70.0 | $60.0 | $60.0 | $60.0 | $35.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$21.2 | -$32.5 | — | -$34.4 | -$34.0 |
Shares outstanding 76.2M · Free float 39.0%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.